Raise closed, search for fresh raises on Seedstage

Scottsdale, AZ

Deploying AI-powered infrared diagnostics and therapies to transform early detection and management of chronic inflammatory diseases.

• Comprehensive platform: Combines AI, medical imaging, and physician training with FDA-cleared technology and patented medical food
• Early detection focus: Enables non-invasive, real-time diagnosis of inflammation-linked diseases before symptoms escalate
• Strong market tailwinds: Tapping into fast-growing sectors like medical imaging AI and preventive care
• Validated and in use: Products already adopted by practitioners with growing pre-orders and projected revenue
• Mission-driven leadership: Team includes medical, legal, and veteran healthcare experts with commercial and regulatory experience

Oxygen4Life is building an AI-powered healthcare platform aimed at early detection and personalized management of chronic inflammatory diseases. Its ecosystem includes FDA-cleared infrared imaging hardware, proprietary AI diagnostics, and patented medical food therapies. This integrated solution addresses key shortcomings in the current healthcare system, which is heavily focused on treating illness rather than preventing it. By identifying inflammatory issues before symptoms escalate, Oxygen4Life aims to reduce costs and improve outcomes in areas such as diabetes, cardiovascular conditions, PTSD, and neurodegenerative diseases.

The company is raising funds to scale operations, expand physician training, and grow market adoption of its technologies. Oxygen4Life plans to enhance its AI model with continuous data learning, increase participation in industry events, and support ongoing regulatory and administrative efforts. Proceeds will also support marketing, hiring, and global expansion. With products already in market and strategic partnerships in development, the company is positioned to disrupt a healthcare system burdened by chronic disease through early, non-invasive diagnostics and evidence-backed therapeutic solutions.

Company Info

Oxygen4Life offers FDA-cleared, AI-driven diagnostic and therapeutic solutions for early detection and management of chronic inflammatory diseases.

Oxygen4Life is a healthcare technology company offering an integrated suite of FDA-cleared solutions to detect and manage chronic inflammatory diseases using AI-powered diagnostics and infrared imaging. Their flagship technologies include the ThermaLens IRIS-XP imaging system, AiLLUMI diagnostic software, and Brivanta, a patented plant-based medical food for managing inflammation. These products target early detection and proactive treatment of conditions such as neuropathy, cardiovascular disease, and diabetes-related complications.

The company also operates InfraREDMed, a physician training platform that supports adoption of its technologies across clinical settings. By combining diagnostic imaging, AI, and physician-guided treatment options, Oxygen4Life addresses systemic inefficiencies in the current reactive healthcare model. Their solutions aim to reduce healthcare costs, improve patient outcomes, and empower medical professionals with tools for early detection and intervention.